Brief: Glenmark Pharmaceuticals Inc USA Continues To Expand Its Over-The-Counter (OTC) Portfolio With Acquisition Of Approved Andas From Wockhardt Limited
28/06/2022 13:33
June 28 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS :
* GLENMARK PHARMACEUTICALS INC., USA CONTINUES TO EXPAND ITS
OVER-THE-COUNTER (OTC) PORTFOLIO WITH THE ACQUISITION OF
APPROVED ANDAS FROM WOCKHARDT LIMITED
Source text for Eikon: ID:nPnbq6rbta
Further company coverage: GLEN.NS
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter